GlassScriptPhysician profile
Megan Solomon Gau
NPI 1669908265
$6,705.11
in general payments reported to CMS, 2019-2025
19 companies · $145 in 2025
The $145 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17.33 · 2020: $72.52 · 2021: $5,400 · 2022: $329 · 2023: $354 · 2024: $387 · 2025: $145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $776 · Education: $110.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $775.69 |
| Education | $110.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,756.46 | 2021-2022 | |
| Abbvie INC. | $536.52 | 2021-2024 | |
| Acacia Pharma INC | $253.06 | 2021 | |
| Astellas Pharma US INC | $176.42 | 2023-2025 | Veozah |
| Sage Therapeutics, LLC | $160.97 | 2024-2025 | Zurzuvae |
| Exeltis, USA INC. | $149.77 | 2023-2025 | Slynd |
| Medical Device Business Services, INC. | $121.83 | 2021 | |
| Hologic Sales and Service, LLC | $95.38 | 2021-2024 | Aptima, Thinprep 2000 Processor |
| Apyx Medical Corporation | $72.52 | 2020 | |
| Mayne Pharma Commercial LLC | $69.05 | 2022-2025 | |
| Millicent US INC | $64.87 | 2024 | Femring, Intrarosa |
| Aspira Women'S Health INC | $56.42 | 2021-2024 | Ova1 |
| Bayer Healthcare Pharmaceuticals INC. | $51.81 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $38.59 | 2019-2023 | Gardasil 9 |
| Smith+Nephew, INC. | $26.73 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $21.71 | 2022 | |
| Organon LLC | $21.10 | 2023 | Nexplanon |
| Shield Therapeutics INC | $16.75 | 2023 | Accrufer |
| Coloplast Corp | $15.15 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Megan Gau listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.